Literature DB >> 19168822

Magnetic resonance imaging, magnetic resonance spectroscopy, and facial dysmorphism in a case of Lowe syndrome with novel OCRL1 gene mutation.

Adnan Yuksel1, Ender Karaca, M Sait Albayram.   

Abstract

Lowe syndrome is a multisystem disorder characterized by anomalies of the eye, the nervous system, and the kidney. It is an uncommon, X-linked disease. Bilateral cataract and severe hypotonia are present at birth. Psychomotor retardation is evident in childhood, while renal complications arise in adolescence. The mutation of the gene OCRL1 localized at Xq26.1 is responsible for the disease. The authors report on a 12-year-old male with mental retardation, facial dysmorphism as prominent forehead, long and slender-shaped face, prominent eyebrows, epicanthus, microphthalmia, low-posterior set ears with prominent helix and antihelix, long philtrum, and mild prognathia. He also had history of neonatal hypotonia and congenital cataracts. His cranial magnetic resonance imaging showed increased signal intensity in white matter on T2-weighted images, and magnetic resonance spectroscopy revealed elevation of the myoinositol peak at 3.56 ppm. Molecular analysis of OCRL1 gene revealed novel N574K mutation on 17th exon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168822     DOI: 10.1177/0883073808321047

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1.

Authors:  Laura E Swan; Livia Tomasini; Michelle Pirruccello; Joël Lunardi; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

2.  Management of cataract surgery in Lowe syndrome.

Authors:  Katharina Eibenberger; Sandra Rezar-Dreindl; Franz Pusch; Ursula Schmidt-Erfurth; Eva Stifter
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

3.  Recognition of the F&H motif by the Lowe syndrome protein OCRL.

Authors:  Michelle Pirruccello; Laura E Swan; Ewa Folta-Stogniew; Pietro De Camilli
Journal:  Nat Struct Mol Biol       Date:  2011-06-12       Impact factor: 15.369

4.  Impaired neural development in a zebrafish model for Lowe syndrome.

Authors:  Irene Barinaga-Rementeria Ramirez; Grzegorz Pietka; David R Jones; Nullin Divecha; A Alia; Scott C Baraban; Adam F L Hurlstone; Martin Lowe
Journal:  Hum Mol Genet       Date:  2011-12-30       Impact factor: 6.150

5.  Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.

Authors:  Emilie Song; Na Luo; Jorge A Alvarado; Maria Lim; Cathleen Walnuss; Daniel Neely; Dan Spandau; Alireza Ghaffarieh; Yang Sun
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

6.  Temper outbursts in Lowe syndrome: Characteristics, sequence, environmental context and comparison to Prader-Willi syndrome.

Authors:  Helen Cressey; Chris Oliver; Hayley Crawford; Jane Waite
Journal:  J Appl Res Intellect Disabil       Date:  2019-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.